NSF International appointment
This article was originally published in The Tan Sheet
Kevan Lawlor named President & CEO, organization announces Sept. 15. During his 18-year tenure at NSF, Lawlor has held positions that include Chief Financial Officer, Senior VP-Food Safety and President of International Strategic Registrations. Lawlor replaces outgoing CEO Dennis R. Mangino. His appointment became effective Sept. 10...
You may also be interested in...
CEO Werner Baumann admits he was skeptical at first as to whether the German group had the necessary know-how to manufacture vaccines but the firm's expertise in the development of biotech products has strengthened his belief Bayer can deliver.
As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.